Pakistan’s Riphah International University and Chinese medical artificial intelligence company Tairex have signed a strategic cooperation agreement to advance plans for an AI-powered hospital in Pakistan.
The agreement was signed on November 17 at Tairex’s office in Beijing. Riphah officials also joined the ceremony online from Pakistan.
The partnership will explore AI hospital development, AI-assisted diagnosis and treatment, medical education, professional training and joint healthcare research. A report by Computerworld Pakistan described the arrangement as a three-year Memorandum of Understanding (MoU), providing a framework for the two organisations to identify potential projects.
Riphah Sees AI as a Way to Expand Healthcare Access
Riphah Chancellor Hassan Muhammad Khan said Pakistan faced financial constraints and difficulties providing healthcare services in remote and underserved areas.
He described the partnership as an opportunity to improve healthcare delivery, from primary care to specialised medical services.
Khan said he hoped artificial intelligence could help extend medical services to communities with limited access to healthcare. He also expressed a vision of bringing healthcare closer to people in both developing and advanced economies.
He pledged the university’s continued support for the teams working on the collaboration, including their organisational and budgetary requirements.
Khan also highlighted the potential impact on medical education. He said joint research and practical experience could help Riphah update its curriculum and prepare future healthcare professionals to work with emerging medical technologies.
Tairex to Contribute Healthcare AI Technology
James Li, Tairex’s president and chief marketing officer, said the partnership would combine the company’s healthcare AI technology with Riphah’s experience in medical education, research and Pakistan’s healthcare sector.
He said the collaboration aimed to develop solutions based on actual medical needs rather than technology alone.
Li added that clinical judgement, patient safety and data privacy would remain priorities as both sides explored AI applications in hospital services, medical education and research.
The partners aim to translate their plans into practical initiatives that could benefit healthcare professionals, students and patients.
What Is Tairex’s Agent Hospital System?
Tairex was established in September 2024 and incubated by Tsinghua University’s Institute for AI Industry Research (AIR). Its main healthcare project, Agent Hospital, uses artificial intelligence agents to simulate clinical environments and support different medical workflows.
The system allows medical students and doctors to practise consultations with virtual patients. It is designed to provide a controlled environment where healthcare professionals can develop clinical reasoning and practise responding to different medical scenarios.
Tairex also describes several AI-assisted functions for healthcare settings, including preliminary patient consultations, clinical decision support, medical record preparation and follow-up care. Its technology is intended to assist medical professionals rather than replace their clinical responsibility.
In October, the company introduced a Multidisciplinary Human-Agent Collaboration ecosystem for Agent Hospital. The system is designed to let specialised AI agents work alongside physicians on clinical cases, supporting collaboration across medical disciplines.
Partnership Builds on October Discussions
The latest agreement follows an initial public announcement of the proposed collaboration in Beijing on October 21.
A report published by China Economic Net on October 23 said Riphah was interested in introducing Tairex’s Agent Hospital system in Pakistan. The proposed areas of cooperation included virtual consultation rooms for medical training, AI-assisted clinical decision-making and patient follow-up research.
Speaking at the November signing ceremony, Khan recalled visiting a hospital in Beijing several months earlier. He said he had observed AI applications in outpatient services and discussed their use with a paediatrics specialist.
The agreement was signed by Sarfraz Haroon, Riphah’s director of the Computer Services Department, and Qiao Yuchen, Tairex’s legal representative and chief product officer.
Implementation and Patient Safety Remain Key Priorities
The partnership could create opportunities to assess how AI technology can support Pakistan’s hospitals, medical institutions and healthcare education system.
However, signing the agreement does not mean an AI hospital has already been established or that the technology has received approval for clinical deployment in Pakistan.
Further arrangements will be needed to determine specific projects, implementation plans and responsibilities. Computerworld Pakistan reported that clinical deployment and any use of patient data would require separate agreements and relevant institutional, ethical and regulatory approvals.
The collaboration therefore represents an initial step towards exploring AI-enabled healthcare in Pakistan. Its longer-term impact will depend on how effectively the partners adapt the technology to local medical needs while maintaining clinical oversight, patient safety and data protection.
Read More Articles:
China and Pakistan Deepen Governance Cooperation Following CPC Fifth Plenum














